| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Cognitive Dysfunction; Disease; Personality Disorders; Schizotypal Personality Disorder | Phase 2 | ClinicalTrials |
CONTENTS
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Cognitive Dysfunction; Disease; Personality Disorders; Schizotypal Personality Disorder | Phase 2 | ClinicalTrials |